Advertisement
Screener

CRONOS GROUP INC. (CRON) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Capital Expenditures

CRONOS GROUP INC. (CRON) reported Capital Expenditures of $3.61 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06

  • CRONOS GROUP INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.74M, a 54.68% decline year-over-year.
  • CRONOS GROUP INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.88M, a 87.71% decline year-over-year.
  • CRONOS GROUP INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $2.14M, a 39.63% decline year-over-year.
  • CRONOS GROUP INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $4.48M, a 30.12% decline year-over-year.
  • CRONOS GROUP INC. payments to acquire property, plant, and equipment for fiscal 2025 was $25.72M, a 107.21% increase from fiscal 2024.
  • CRONOS GROUP INC. payments to acquire property, plant, and equipment for fiscal 2024 was $12.41M, a 395.45% increase from fiscal 2023.
  • CRONOS GROUP INC. payments to acquire property, plant, and equipment for fiscal 2023 was $2.50M, a 27.41% decline from fiscal 2022.
  • CRONOS GROUP INC. payments to acquire property, plant, and equipment for fiscal 2022 was $3.45M, a 69.03% decline from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2026-06-30$1.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$3.61M
10-Q · filed 2026-08-06
$5.75M
derived: sum of 3 quarters · filed 2026-08-06
$10.24M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.88M
10-Q · filed 2026-05-11
$4.01M
derived: sum of 2 quarters · filed 2026-05-11
$8.50M
derived: sum of 3 quarters · filed 2026-05-11
$12.33M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$2.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$6.62M
derived: sum of 2 quarters · filed 2026-02-26
$10.46M
derived: sum of 3 quarters · filed 2026-08-06
$25.72M
10-K · filed 2026-02-26
2025-09-30$4.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$8.32M
derived: sum of 2 quarters · filed 2026-08-06
$23.58M
10-Q · filed 2025-11-06
$27.12M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$3.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$19.09M
10-Q · filed 2026-08-06
$22.64M
derived: sum of 3 quarters · filed 2026-08-06
$29.05M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$15.26M
10-Q · filed 2026-05-11
$18.80M
derived: sum of 2 quarters · filed 2026-05-11
$25.22M
derived: sum of 3 quarters · filed 2026-05-11
$25.95M
derived: sum of 4 quarters · filed 2026-05-11
2024-12-31$3.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$9.96M
derived: sum of 2 quarters · filed 2026-02-26
$10.69M
derived: sum of 3 quarters · filed 2026-02-26
$12.41M
10-K · filed 2026-02-26
2024-09-30$6.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$7.14M
derived: sum of 2 quarters · filed 2025-11-06
$8.87M
10-Q · filed 2025-11-06
$10.09M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$729.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$2.45M
10-Q · filed 2025-08-07
$3.67M
derived: sum of 3 quarters · filed 2026-02-26
$3.66M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$1.72M
10-Q · filed 2025-05-08
$2.94M
derived: sum of 2 quarters · filed 2026-02-26
$2.93M
derived: sum of 3 quarters · filed 2026-02-26
$3.42M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$1.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$1.21M
derived: sum of 2 quarters · filed 2026-02-26
$1.70M
derived: sum of 3 quarters · filed 2026-02-26
$2.50M
10-K · filed 2026-02-26
2023-09-30-$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$483.00K
derived: sum of 2 quarters · filed 2024-11-12
$1.29M
10-Q · filed 2024-11-12
$1.65M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$494.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$1.30M
10-Q · filed 2024-08-08
$1.66M
derived: sum of 3 quarters · filed 2025-02-27
$2.53M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$804.00K
10-Q · filed 2024-05-09
$1.17M
derived: sum of 2 quarters · filed 2025-02-27
$2.04M
derived: sum of 3 quarters · filed 2025-02-27
$3.54M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$364.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$1.23M
derived: sum of 2 quarters · filed 2025-02-27
$2.74M
derived: sum of 3 quarters · filed 2025-02-27
$3.45M
10-K · filed 2025-02-27
2022-09-30$869.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$2.38M
derived: sum of 2 quarters · filed 2023-11-08
$3.09M
10-Q · filed 2023-11-08
$3.58M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$1.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$2.22M
10-Q · filed 2023-08-08
$2.71M
derived: sum of 3 quarters · filed 2024-02-29
$5.01M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$711.00K
10-Q · filed 2023-05-09
$1.20M
derived: sum of 2 quarters · filed 2024-02-29
$3.51M
derived: sum of 3 quarters · filed 2024-02-29
$5.17M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$493.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$2.80M
derived: sum of 2 quarters · filed 2024-02-29
$4.46M
derived: sum of 3 quarters · filed 2024-02-29
$11.14M
10-K · filed 2024-02-29
2021-09-30$2.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$3.97M
derived: sum of 2 quarters · filed 2022-11-07
$10.65M
10-Q · filed 2022-11-07
$20.73M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$1.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$8.35M
10-Q · filed 2022-08-09
$18.43M
derived: sum of 3 quarters · filed 2023-02-28
$26.41M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$6.68M
10-Q · filed 2022-05-10
$16.76M
derived: sum of 2 quarters · filed 2023-02-28
$24.75M
derived: sum of 3 quarters · filed 2023-02-28
$31.68M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$10.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$18.07M
derived: sum of 2 quarters · filed 2023-02-28
$25.00M
derived: sum of 3 quarters · filed 2023-02-28
$31.41M
10-K · filed 2023-02-28
2020-09-30$7.99M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18
$14.92M
derived: sum of 2 quarters · filed 2022-02-18
$21.33M
10-Q · filed 2022-02-18
$22.38M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$6.93M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18
$13.34M
10-Q/A · filed 2022-02-18
$14.39M
derived: sum of 3 quarters · filed 2022-03-01
$31.09M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$6.41M
10-Q · filed 2021-05-07
$7.45M
derived: sum of 2 quarters · filed 2022-03-01
$24.16M
derived: sum of 3 quarters · filed 2022-03-01
$34.96M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$17.75M
derived: sum of 2 quarters · filed 2022-03-01
$28.55M
derived: sum of 3 quarters · filed 2022-03-01
$38.66M
10-K · filed 2022-03-01
2019-09-30$16.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$27.50M
derived: sum of 2 quarters · filed 2020-11-05
$37.62M
10-Q · filed 2020-11-05
2019-06-30$10.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$20.92M
10-Q · filed 2020-08-06
2019-03-31$10.12M
10-Q · filed 2020-05-08
2018-12-31$88.31M
10-K · filed 2021-02-26
2017-12-31$32.93M
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87